Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney Diseases
|
140 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.010 | 1 | 2004 | 2004 | |||||
Metabolic Syndrome X
|
591 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.010 | 1 | 2014 | 2014 | |||||
Ovarian Failure, Premature
|
115 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.010 | 1 | 2016 | 2016 | |||||
Premature Menopause
|
90 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.010 | 1 | 2016 | 2016 | |||||
Rheumatoid Arthritis
|
2387 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.010 | 1 | 2018 | 2018 | |||||
cervical cancer
|
268 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2011 | 2018 | ||||
Cervix carcinoma
|
283 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2011 | 2018 | ||||
Deep Vein Thrombosis
|
93 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2008 | 2018 | ||||
Folic Acid Deficiency
|
8 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2015 | 2015 | ||||
Malignant tumor of cervix
|
245 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2011 | 2018 | ||||
Multiple Myeloma
|
865 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2007 | 2008 | ||||
Multiple Sclerosis
|
1022 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.020 | 0.500 | 2 | 2007 | 2019 | ||||
Male infertility
|
146 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.060 | 0.667 | 6 | 2014 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.070 | 0.714 | 7 | 2008 | 2016 | ||||
Malignant neoplasm of breast
|
3417 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.070 | 0.714 | 7 | 2008 | 2016 | ||||
Colorectal Carcinoma
|
1962 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.040 | 0.750 | 4 | 2002 | 2017 | ||||
Neural Tube Defects
|
122 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.100 | 0.846 | 13 | 1999 | 2019 | ||||
Complete Trisomy 21 Syndrome
|
77 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.100 | 0.889 | 18 | 2000 | 2017 | ||||
Down Syndrome
|
80 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.100 | 0.895 | 19 | 2000 | 2017 | ||||
Coronary heart disease
|
1178 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.100 | 0.900 | 10 | 2003 | 2018 | ||||
Coronary Artery Disease
|
1577 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.050 | 1.000 | 5 | 2003 | 2015 | ||||
Carcinoma of lung
|
1204 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.040 | 1.000 | 4 | 2005 | 2019 | ||||
Congenital Heart Defects
|
58 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.040 | 1.000 | 4 | 2006 | 2017 | ||||
Malignant neoplasm of lung
|
1142 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.040 | 1.000 | 4 | 2005 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.531 | 0.840 | 5 | 7870860 | missense variant | A/G | snv | 0.47 | 0.45 | 0.040 | 1.000 | 4 | 2008 | 2017 |